Forzinity (Elamipretide)

Elamipretide is a medicine for Barth syndrome, a rare genetic condition that causes weak muscles and heart problems. It is given as a shot under the skin. It works by helping the tiny power plants inside cells, called mitochondria, work better.

Brand names:Forzinity
Medication

What people taking Forzinity (Elamipretide) report

Every report comes from a Lived member, sent anonymously.

Have you tried Forzinity (Elamipretide) for Mitochondrial Diseases?

NameHow it went

About Forzinity (Elamipretide)

What It's For

Elamipretide, sold as Forzinity, is a prescription injection for Barth syndrome, a rare inherited condition that weakens the heart and the muscles used for movement and often lowers a type of white blood cell that fights infection. Barth syndrome affects almost only males. Forzinity is approved to improve muscle strength in adults and children with Barth syndrome who weigh at least 30 kg (about 66 pounds). It has not been shown to be safe or effective in lighter children and is not approved for newborns. It is the first medicine approved in the US specifically for this condition. The US Food and Drug Administration (FDA) granted it accelerated approval in 2025. That pathway allows a medicine for a serious condition with few options to reach patients based on an early measure, here leg muscle strength, before a full benefit on daily life has been proven. Keeping the approval depends on a further confirmatory study. Forzinity adds to, rather than replaces, the usual Barth syndrome care, such as heart medicines and treatment to prevent or manage infections.

How It Works

Mitochondria are the structures inside cells that turn food into usable energy. Their inner membrane depends on a fat called cardiolipin to keep its shape and run energy production. In Barth syndrome, a change in the gene for a protein called tafazzin means the body cannot finish building cardiolipin properly, so mitochondria are misshapen and produce less energy. Heart and skeletal muscle, which use a great deal of energy, are hit hardest. Elamipretide is a small protein-like molecule that travels to the inner mitochondrial membrane and binds to cardiolipin. This is thought to help stabilize the membrane and improve how mitochondria work. It does not correct the underlying gene change, so it is a long-term treatment rather than a cure, and how much this translates into everyday strength or stamina differs between people.

Dosage & Administration

Forzinity is a liquid given as an injection just under the skin once a day, at about the same time each day. The usual dose is 40 mg. Adults with severe kidney impairment who are not on dialysis usually take half that dose, and there is no established dose for people on dialysis or for children with kidney impairment. After training from the care team, many adults or caregivers give the injection at home. It goes into the abdomen (at least 2 inches from the belly button) or the outer thigh, with the site changed every day. Skin that is tender, bruised, red, hard or scarred should be avoided. Each vial holds several doses for one person, is checked before use for cloudiness or particles, and is thrown away 8 days after it is first opened, even if some is left. Unopened vials are kept in the refrigerator and not frozen. If a dose is missed, skip it and take the next one at the usual time. Do not take two doses to make up for a missed one.

Side Effects

Injection site reactions are the most common side effect and in the main trial occurred in everyone taking elamipretide. Redness at the site was universal, and pain, hardening, itching, bruising and hives at the site were also common. These are usually mild and can often be eased with antihistamines or a steroid cream recommended by the care team. Rotating injection sites helps. Allergic reactions, including serious ones that needed emergency treatment, have been reported. They can begin within minutes or appear months after starting. Milder signs include rash, bumpy or eczema-like skin patches and cough; tell the care team about a rash or skin reaction that persists or worsens, since stopping treatment may be considered. Signs of a sudden severe allergic reaction, such as trouble breathing, swelling of the face, lips or throat, or widespread hives soon after a dose, call for stopping the medicine and getting emergency medical care right away.

Interactions & Warnings

Anyone who has had a serious allergic reaction to elamipretide or any ingredient in Forzinity should not take it again. No important drug interactions are listed in the US prescribing information, and laboratory studies show it does not interfere with the liver enzymes that break down many common medicines. The prescriber and pharmacist should still have a complete list of medicines and supplements, since experience with the drug is limited. Forzinity contains benzyl alcohol as a preservative. In very small or premature newborns, benzyl alcohol has caused a dangerous, sometimes fatal condition, which is one reason the medicine is not approved for newborns. Because Barth syndrome almost never affects females, there is no information on use during pregnancy or breastfeeding.

What to Expect

Improvement, if it comes, is gradual. In the main trial, 12 weeks of elamipretide did not improve walking distance, fatigue or leg strength compared with a placebo (an inactive injection). In the longer follow-up, where everyone took the medicine and there was no comparison group, leg strength rose over months, and a published report on the eight people who stayed on it for about three years described better walking distance, less fatigue and some improvement in heart measurements. These results come from a very small group, so it is not yet known how reliably the benefit carries over to daily life or who is most likely to respond. Treatment is meant to be ongoing, alongside regular care for the heart, infections and growth. Routine blood tests may show a rise in eosinophils, a type of white blood cell, that often peaks around three months and settles over the following months; in studies it caused no symptoms. Follow-up visits are a chance to review strength, energy and skin reactions, and to discuss whether the treatment is worth continuing.

Questions to Ask Your Doctor

  1. 1.What improvement in strength or energy might be realistic for me, and how will we measure whether it is working?
  2. 2.What does the accelerated approval mean for my treatment if the confirmatory study does not show a clear benefit?
  3. 3.Who will teach me or my caregiver to give the daily injections, and how should we manage skin reactions at the site?
  4. 4.Does my kidney function change the dose I should take?
  5. 5.How does this medicine fit with the heart and infection care I already receive?

Last reviewed • Oct 2026

Educational content, not medical advice.